May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary...
Ablation Systems
This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems.
An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures.
News | Atrial Fibrillation | May 14, 2019 | Dave Fornell, Editor
News | Ablation Systems | May 13, 2019
May 13, 2019 — Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague,...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.
Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has...
Robotic electrophysiology operating room including Stereotaxis Genesis RMN and Stereotaxis Imaging Model S systems. Image courtesy of Stereotaxis.
News | Robotic Systems | May 09, 2019
May 9, 2019 – Stereotaxis introduced Stereotaxis Genesis RMN, its next-generation...
News | EP Mapping and Imaging Systems | May 09, 2019
May 9, 2019 — Philips announced a collaboration with Medtronic to further advance treatment of...
News | Ablation Systems | May 08, 2019
May 8, 2019 — Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new...
Technology | EP Mapping and Imaging Systems | April 26, 2019
April 26, 2019 — Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation...
News | Ablation Systems | April 16, 2019
April 16, 2019 — CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic...
The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.
Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the...
News | Ablation Systems | February 04, 2019
February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S....
News | EP Mapping and Imaging Systems | January 28, 2019
January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the...
Technology | Ablation Systems | January 21, 2019
January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force...
A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews.
Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.
In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S. government...
